Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
复制标题
DOI:
10.1172/jci59903
复制
发表时间:
2012-04-01
影响因子:
15.9
通讯作者:
Arnold, Steven E.
中科院分区:
文献类型:
--
作者:
Talbot, Konrad;Wang, Hoau-Yan;Arnold, Steven E.
While a potential causal factor in Alzheimer's disease (AD), brain insulin resistance has not been demonstrated directly in that disorder. We provide such a demonstration here by showing that the hippocampal formation (HF) and, to a lesser degree, the cerebellar cortex in AD cases without diabetes exhibit markedly reduced responses to insulin signaling in the IR -> IRS-1 -> PI3K signaling pathway with greatly reduced responses to IGF-1 in the IGF-1R -> IRS-2 -> PI3K signaling pathway. Reduced insulin responses were maximal at the level of IRS-1 and were consistently associated with basal elevations in IRS-1 phosphorylatecl at serine 616 (IRS-1 pS(616)) and IRS-1 pS(636/639). In the HF, these candidate biomarkers of brain insulin resistance increased commonly and progressively from normal cases to mild cognitively impaired cases to AD cases regardless of diabetes or APOE epsilon 4 status. Levels of IRS-1 pS(616) and IRS-1 pS(636/639) and their activated kinases correlated positively with those of oligomeric A beta plaques and were negatively associated with episodic and working memory, even after adjusting for A beta plaques, neurofibrillary tangles, and APOE epsilon 4. Brain insulin resistance thus appears to be an early and common feature of AD, a phenomenon accompanied by IGF-1 resistance and closely associated with IRS-1 dysfunction potentially triggered by A beta oligomers and yet promoting cognitive decline independent of classic AD pathology.